Cocaine Use Treatment Study
Researchers at the University of Arkansas for Medical Sciences are partnering with individuals who use cocaine regularly and want to quit to evaluate how a combination of two medications can help. Join our compensated study today!
Fast Facts
active cocaine and/or crack use
interested in quitting or reducing cocaine use
18-65 years old
Compensation Provided
Conducted in Little Rock, AR
Study Background
Despite research efforts, there are not yet any approved medications for cocaine use disorder. Several medications have been studied in the past, but none have been consistently effective. That’s why we’re working to find a treatment strategy that can help people reduce their cocaine use.
In this study, we will examine the effect of two medications: extended-release naltrexone and extended-release buprenorphine. This is a double-blind placebo-controlled study, meaning that some participants will get a combination of the two active medications, and some participants will get a dummy medication that has no effect, so that we can compare the outcomes.
Your participation in this study may help researchers improve treatment approaches for cocaine use disorder. Advance research today and join our compensated study!
Study Background
Despite research efforts, there are not yet any approved medications for cocaine use disorder. Several medications have been studied in the past, but none have been consistently effective. That’s why we’re working to find a treatment strategy that can help people reduce their cocaine use.
In this study, we will examine the effect of two medications: extended-release naltrexone and extended-release buprenorphine. This is a double-blind placebo-controlled study, meaning that some participants will get a combination of the two active medications, and some participants will get a dummy medication that has no effect, so that we can compare the outcomes.
Your participation in this study may help researchers improve treatment approaches for cocaine use disorder. Advance research today and join our compensated study!
Additional Information
You may qualify for this study if you meet the following criteria.
Key Criteria:
- 18-65 years old
- Active cocaine and/or crack use
- Interested in quitting or reducing your cocaine use
- Not pregnant, breastfeeding, or planning to become pregnant
Once enrolled, this 16-week study involves:
- Screening/baseline period (3 weeks)
- Being randomly assigned to receive either the active medication or a placebo (dummy medication) (1 week)
- Medication phase, where you will have study visits twice a week and receive medication injections during some visits (8 weeks)
- Follow-up visits (4 weeks)
Contact the study team: 501-526-7969